Skip to main content
. 2019 Dec 2;59(4):447–462. doi: 10.1007/s40262-019-00844-3

Fig. 2.

Fig. 2

Decision-making tree for selecting a mitigation strategy. ARA acid-reducing agent, CYP cytochrome P450, H2RA histamine H2 receptor antagonist, PPI proton pump inhibitor